MetaCap

American Shared Hospital Services (AMS) vs Sera Prognostics (SERA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Sera Prognostics is the larger company by market cap ($81.7 million vs $9.0 million), about 9.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

AMS versus SERA key metrics
MetricAMSSERA
Share price$1.35$2.07
Market cap$8.98M$81.66M
1-day change-2.17%+0.98%
YTD return—-29.83%
1-year return—-36.31%
5-year return—-80.92%
EPS (TTM)$-0.26$-0.67
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.48$3.95
52-week low$1.25$1.56
Distance from 52-week high-45.56%-47.59%
Average volume14.83K28.59K
Shares outstanding6.65M38.48M
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Sera Prognostics is about 9.1 times larger than American Shared Hospital Services by market value ($81.66M vs $8.98M).

AMS vs SERA FAQ

Which is bigger, American Shared Hospital Services or Sera Prognostics?

Sera Prognostics (SERA) is larger, with a market capitalization of $81.66M compared with $8.98M for American Shared Hospital Services (AMS).

Are American Shared Hospital Services and Sera Prognostics in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons